biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > DrDR is AWESOME!!!! EOM

<< Previous

Bullboard Posts

Next >>

Comment by ronrydellon Jan 11, 2021 12:27pm

194 Views

Post# 32267534

RE:RE:RE:RE:DrDR is AWESOME!!!! EOM

It's great to see this bump...especially with no news. I suspect that it's the anticipation that some is "in the wind" and if we get some news we'll jump even more....it also could go back down like it did after last June's licensing agreement. Here's hoping!!

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"